INTRODUCTION
Guillain-Barré syndrome (GBS) was first described in 1916. (1) It is a devastating neurological disease. The acute phase of the disease is characterised by generalised paralysis, bulbar muscle weakness and respiratory failure. Immune-mediated inflammation of the myelin sheath of peripheral nerves is a known pathogenesis. (2) The overall incidence of GBS ranges from 1.1:100,000 to 1.8:100,000, but is higher (1.7-3.3:100,000) among persons aged above 50 years. (3) Antecedent systemic infections, such as respiratory tract infections and gastroenteritis, are associated with 70% of all GBS cases. (3) For these patients, complications related to prolonged mechanical ventilation and immobilisation are significant causes of morbidity and mortality. As GBS patients may benefit from early treatment (e.g. tracheostomy and intensive respiratory care), this retrospective study was conducted to determine the clinical presentations of patients with GBS that are associated with the need for: (a) mechanical ventilation; and (b) prolonged mechanical ventilation (> 15 days).
METHODS
Patients aged ≥ 15 years who were diagnosed with GBS (according to Asbury and Cornblath's diagnostic criteria) (4) in Songklanagarind Hospital, Hat Yai, Thailand, from January 2001 to December 2010 were included in this study. Patients who had other specific types of polyneuropathy (e.g. diabetic polyneuropathy, thiamine deficiency polyneuropathy, polyneuropathy due to industrial agents or drugs, porphyria and polyneuropathy associated with human immunodeficiency virus infection) were excluded. Electrophysiological criteria for the diagnosis of GBS were met in all enrolled cases.
The following data was collected from the medical records of all enrolled patients: patient demographics; history of antecedent infections (e.g. respiratory tract infection and gastroenteritis) or vaccinations; presenting neurological symptoms; Hughes severity score (HSS) at presentation and discharge; time to peak limb weakness; results of cerebrospinal fluid (CSF) analysis; total number of days for which ventilation support was needed; and treatment options. Time to peak limb weakness refers to the duration from the onset of the first neurological symptoms to the time the most severe limb weakness was experienced. Clinical presentations that were predictors of respiratory insufficiency (i.e. the need for ventilator support) and the need for prolonged ventilation support (> 15 days) were determined by univariate logistic regression analysis. 
RESULTS
A total of 55 patients with GBS who met the inclusion criteria were identified using the hospital's computer information system. Among these 55 patients, 28 (50.9%) were male and 27 (49.1%) were female. The mean age was 50.15 ± 15.84 (range 17-86) years. Antecedent infections were reported in 14 (25.5%) of the patients; 10 (18.2%) patients had upper respiratory tract infections and 4 (7.3%) had gastroenteritis. Two patients had been vaccinated before the onset of GBS -one with a rabies vaccine and the other with an influenza vaccine. 54 (98.2%) of the 55 patients presented with progressive weakness in more than one limb. Additionally, 20 (36.4%) had bulbar muscle weakness, 18 (32.7%) had lower motor neuron facial paresis (unilateral or bilateral) and 4 (7.3%) had ptosis. The mean time to peak limb weakness was 6.96 ± 4.90 (range 1-21) days. The patients' HSS at admission were as follows: score 1 (n = 0); score 2 (n = 2, 3.6%); score 3 (n = 13, 23.6%); score 4 (n = 23, 41.8%); and score 5 (n = 17, 30.9%). The mean CSF protein level was 178.37 ± 187.78 (range 24-980) mg/dL and the mean CSF white blood cell count was 4.02 ± 8.59 (range 0-50) cells/mm 3 ( Table I) .
Among the 55 patients, 28 (50.9%) had respiratory failure that required mechanical ventilation. Among these 28 patients, 20 (71.4%) required prolonged mechanical ventilation (> 15 days), 5 (17.9%) were mechanically ventilated for less than 15 days and 3 (10.7%) were discharged against advice or transferred. A tracheostomy was indicated in 10 of the 28 (35.7%) patients. The mean number of days on mechanical ventilation was 30.68 ± 62.05 (range 6-330) days. All mechanically ventilated patients were treated using plasma exchange or intravenous immunoglobulin.
In this study, we found that bulbar muscle weakness and shorter time to peak limb weakness were significant predictors of the need for mechanical ventilation. There was a significantly higher proportion of patients with bulbar muscle weakness in the group of 28 patients who were mechanically ventilated (n = 15, 53.6%) than in the group of 27 patients who were not mechanically ventilated (n = 5, 18.5%) (odds ratio [OR] 5.08, 95% confidence interval [CI] 1.31-21.60, p = 0.007). The median time to peak limb weakness was significantly shorter among the patients who were mechanically ventilated (5 days; Q1, Q3 = 2.5, 5.5) than among the patients who were not mechanically ventilated (8 days; Q1, Q3 = 6.0, 13.0) (OR 0.75, 95% CI 0.62-0.91, p < 0.001) (Table II) . Other factors, such as age, gender, antecedent upper respiratory tract infection, ptosis, facial paresis, level of CSF protein and CSF white blood cell count, were not found to be associated with the need for mechanical ventilation. When the need for prolonged mechanical ventilation (> 15 days) was considered, we found that both bulbar muscle weakness (p = 0.006) and time to peak limb weakness ≤ 5 days (p < 0.001) were significant predictors (Table III) . 
DISCUSSION
In the present study, we found that the incidences of respiratory failure and requirement for prolonged mechanical ventilation among patients with GBS were higher in our institution than in others. Studies on GBS patients conducted in other tertiary care and medical teaching hospitals have found that the incidence of mechanical ventilation requirement ranged from 8% to 27%. (5, 6) The incidence of mechanical ventilation requirement in the present study was also higher than that reported in an international study (50.9% vs. 25%). (7) This stark contrast may be due to the smaller sample size that was used in the present study, as well as the fact that the present study was based on cases in a single hospital (i.e. there was the possibility of inclusion bias). As our institution is known to be a supertertiary medical care centre in Thailand, most severe cases of GBS would be transferred here for intensive treatment. Hence, nearly three-quarters (i.e. 72.7%) of the patients admitted to our institution for GBS were bedridden and had respiratory insufficiency (HSS grades 4-5) on presentation.
The mean age of the GBS patients in the present study is comparable to that of previous reports. (5, 6, 8) Although antecedent upper respiratory tract infections and gastroenteritis were commonly observed among GBS patients in previous studies (50%), (5, 6, 8, 9) only 14 (25.5%) of the patients in the present study were reported to have such infections.
Bulbar muscle weakness at presentation and time to peak limb weakness ≤ 5 days were found to be significantly associated with the need for mechanical ventilation and its prolonged use (> 15 days) in the present study. As our institution provides treatment to a greater proportion of patients with severe GBS, it is not uncommon that once mechanical ventilation support is initiated, it would be needed for a longer duration. In contrast, age, gender, ptosis, facial paresis, limb weakness, CSF white blood cell count, elevated CSF protein and treatment option showed no association with the need for mechanical ventilation or its prolonged use (> 15 days).
Various clinical presentations have been reported to be predictors of the need for mechanical ventilation. These include: advanced age; rapid disease progression; time from onset to admission of < 7 days; inability to stand, cough or lift elbows or head; cranial nerve palsy; high HSS; dysautonomia; conduction block in electrophysiological study; facial or bulbar weakness; low Medical Research Council sum score; and anti-GQ1b antibody. (10) (11) (12) (13) (14) (15) One study, which investigated the requirement for prolonged mechanical ventilation among patients with GBS who were admitted to an intensive care unit, showed that an inability to perform foot flexion in association with a motor conduction block of the sciatic nerve after completing immunotherapy (either intravenous immunoglobulin or plasma exchange) predicted the need for prolonged mechanical ventilation (> 15 days). (8) We believe that it is essential to identify the clinical presentations that can predict the need for longer mechanical ventilation support at admission, in order to enable timely and appropriate respiratory care for patients with GBS, especially if the hospital has limited advanced laboratory resources. Moreover, well-recognised significant predictors of severe respiratory insufficiency, such as abnormalities in CSF protein, electrophysiological results and the presence of antiganglioside antibodies, would not be apparent until the end of the second week of clinical onset. (11, 16) In other words, an overreliance on the results of these diagnostic tests may delay the identification of GBS patients with a high risk of severe respiratory disability. Furthermore, the occurrence of respiratory complications from prolonged intubation and artificial ventilation can be partly prevented by early tracheostomy. Tracheostomy should be initiated earlier in patients who have severe GBS and are at high risk for prolonged mechanical ventilation. Success in minimising ventilator-associated pulmonary infections will significantly improve the clinical outcome of patients with GBS.
The retrospective nature of the present study and the fact that it was conducted at a single tertiary medical centre limited the strength and generalisability of the study's results. Future systematic and prospective studies should be carried out to elucidate the overall nature of the respiratory insufficiency experienced by patients with GBS, as well as its associated complications.
